Willie Wilson III

Dr. Wilson serves as a Product Quality Team Leader in the Office of Product Quality Assessment III (OPQAIII) located in the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). He is responsible for the assessment of the Chemistry, Manufacturing and Controls (CMC) for therapeutic biological products and biosimilar products throughout the product lifecycle. Dr. Wilson began his service with FDA in 2014. Prior to joining FDA, he served as a post-doctoral research fellow for five years at the National Cancer Institute (NCI) on the campus of the National Institutes of Health, Bethesda, MD.